Biological ActivitySelective μ opioid receptor agonist (IC50 values are 5.5 and > 10000 nM for inhibition of 125I-FK 33,824 and 125I-DADLE binding to μ and δ sites respectively). Produces naloxone-reversible analgesia, catalepsy and hyperthermia following central administration in rats in vivo.
(Modifications:Phe-3 = N-methyl-Phe, Pro-4 = D-Pro & C-terminal amide)
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Potent morphiceptin analogs: structure activity relationships and morphine-like activities.
Chang et al.
Behavioral effects of the μ-opioid peptide agonists DAMGO, DALDA and PL017 on locomotor activities.
Meyer and Meyer
Body temperature and analgesic effects of selective mu and kappa opioid receptor agonists microdialyzed into rat brain.
Xin et al.
No product specific FAQs exist for this product, however you mayView all Peptide FAQs
Reviews for PL 017
There are currently no reviews for this product. Be the first to review PL 017 and earn rewards!
Have you used PL 017?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image